AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $326,717 | -27.2% | 21,854 | -59.9% | 0.00% | – |
Q3 2022 | $449,000 | +39.9% | 54,489 | +11.3% | 0.00% | – |
Q2 2022 | $321,000 | +17.2% | 48,952 | -0.2% | 0.00% | – |
Q1 2022 | $274,000 | -11.9% | 49,028 | -26.2% | 0.00% | – |
Q4 2021 | $311,000 | -45.7% | 66,459 | -28.3% | 0.00% | – |
Q3 2021 | $573,000 | +190.9% | 92,657 | +210.0% | 0.00% | – |
Q2 2021 | $197,000 | -21.2% | 29,892 | -12.7% | 0.00% | – |
Q1 2021 | $250,000 | +138.1% | 34,232 | +88.9% | 0.00% | – |
Q4 2020 | $105,000 | +34.6% | 18,121 | +39.0% | 0.00% | – |
Q3 2020 | $78,000 | -63.6% | 13,033 | -68.5% | 0.00% | – |
Q2 2020 | $214,000 | +2040.0% | 41,359 | +1472.6% | 0.00% | – |
Q1 2020 | $10,000 | – | 2,630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |